Sarcopenia and survival in colorectal cancer without distant metastasis: a systematic review and meta-analysis
- PMID: 38986533
- DOI: 10.1111/jgh.16681
Sarcopenia and survival in colorectal cancer without distant metastasis: a systematic review and meta-analysis
Abstract
Background and aim: Despite prior attempts to evaluate the effects of sarcopenia on survival among patients with colorectal cancer (CRC), the results of these studies have not been consistent. The present study aimed to evaluate the association between sarcopenia and survival among patients having CRC without distant metastasis by aggregating multiple studies.
Methods: We performed a literature search using computerized databases and identified additional studies from among the bibliographies of retrieved articles. The quality of each study was evaluated using the Newcastle-Ottawa Scale, and meta-analyses were performed to evaluate overall survival (OS) and disease-free survival (DFS).
Results: Thirteen studies with up to 6600 participants were included in the meta-analyses, with a mean age of 63.6 years (range: 18-93 years). We found that preoperative sarcopenia was associated with worse OS (hazard ratio [HR]: 1.61; 95% confidence interval [CI]: 1.38-1.88) and worse DFS (HR: 1.57; 95% CI: 1.10-2.24). Compared with patients without sarcopenia after tumor resection, those with postoperative sarcopenia had worse OS (HR: 1.76; 95% CI: 1.47-2.10) and DFS (HR: 1.79; 95% CI: 1.46-2.20).
Conclusion: These meta-analyses suggest that sarcopenia, no matter observed before or after tumor resection, is associated with worse OS and DFS in patients with CRC who have no distant metastasis.
Keywords: colorectal cancer; meta‐analysis; mortality; sarcopenia; survival; systematic review.
© 2024 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
References
-
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 2018; 68: 394–424. https://doi.org/10.3322/caac.21492.
-
- Li Q, An T, Wu J et al. The impact of sarcopenia on the outcome of patients with left‐sided colon and rectal cancer after curative surgery. BMC Cancer 2023; 23: 640.
-
- Charette N, Vandeputte C, Ameye L et al. Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non‐randomized phase II trials. BMC Cancer 2019; 19: 134.
-
- da Cunha LP, Silveira MN, Mendes MCS, Costa FO, Macedo LT, de Siqueira NS, Carvalheira JBC. Sarcopenia as an independent prognostic factor in patients with meta‐static colorectal cancer: a retrospective evaluation. Clin Nutr ESPEN 2019; 32: 107–112. https://doi.org/10.1016/j.clnesp.2019.04.004.
-
- Petersen KF, Befroy D, Dufour S et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science 2003; 300: 1140–1142. https://doi.org/10.1126/science.1082889.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
